Netherlands: Recommended vaccinations
Back to search
Export to spreadsheet
  General recommendation
  Recommendation for specific groups only
  Catch-up (e.g. if previous doses missed)
 		 Vaccination not funded by the National Health system
 		 Mandatory vaccination
BirthMonthsYears
235612143459101418-454950-59≥ 60
Coronavirus disease (COVID-19)
COVID-191
COVID-192
COVID-19
tuberculosis
BCG3
rotavirus infection
ROTA
ROTA
diphtheria
D4
D
D
D
D5
D6
d7
tetanus
TT4
TT
TT
TT
TT5
TT6
TT7
pertussis
acP4
acP
acP
acP
acP5
acp7
poliomyelitis
IPV4
IPV
IPV
IPV
IPV6
Haemophilus influenzae type b infection
Hib4
Hib
Hib
Hib
hepatitis B
HepB8
HepB4
HepB
HepB
HepB
pneumococcal disease
PCV15
PCV15
PCV15
PCV209
meningococcal disease
MCV410
MCV410
measles
MEAS
MEAS
MEAS11
mumps
MUMPS
MUMPS
MUMPS11
rubella
RUBE
RUBE
RUBE11
human papillomavirus infection
HPV2 (F/M)
influenza
IIV12
IIV

Version:


Footnotes:

  1. Recommended to individuals in medical high risk groups aged 6 months and older (https://lci.rivm.nl/richtlijnen/covid-19-vaccinatie#2-vaccinatiestrategie-covid-19)
  2. Recommended to adults 50 to 59 years old that are eligible for influenza vaccination (https://lci.rivm.nl/richtlijnen/covid-19-vaccinatie#2-vaccinatiestrategie-covid-19)
  3. Only given on specific indications. More information available at: https://www.rivm.nl/cpt/richtlijnen-preventie/bcg-vaccinatie
  4. This additional vaccination is recommended only for infants at 2 months of age whose mothers were not vaccinated during pregnancy, and in specific circumstances. In all other cases, infants born to mothers vaccinated during pregnancy (at 22 weeks gestation) receive a two-dose primary series at 3 and 5 months of age.
  5. starting cohort 2021
  6. starting cohort 2016
  7. Recommended for pregnant women from the 22nd weeks of pregnancy until delivery (in every pregnancy)
  8. Offered to infants born to a mother infected with hepatitis B
  9. PCV20 is offered to 60 year old individuals and to people above 60 years of age (five years after their previous invitation for PPV23). In some circumstances, it can also be prescribed to medical high risk groups below 60 years of age by the attending medical doctor and reimbursed by the health insurer. (https://lci.rivm.nl/factsheets/pneumokokkenvaccinatie)
  10. Also prescribed to medical high risk groups of other ages by the attending medical doctor and reimbursed by the health insurer (https://lci.rivm.nl/factsheets/meningokokken-acwy-vaccinatie)
  11. Following shift of MMR vaccine from 9 to 3 years old in 2025, a catch up campaign is in place for cohorts 2016 to 2021 between 2025-27
  12. Indicated to individuals in medical high risk groups of 6 months of age and older and in pregnant women. More information available at: https://lci.rivm.nl/factsheets/influenzavaccinatie


More information available at:
https://rijksvaccinatieprogramma.nl/vaccinaties/vaccinatieschema



----------------------------------------------------------------------------------------------
More information on vaccination available from:

Ministry of Health http://www.rijksoverheid.nl/onderwerpen/vaccinaties

RIVM http://www.rivm.nl/Onderwerpen/Onderwerpen/R/Rijksvaccinatieprogramma

The National Immunisation Programme in the Netherlands: https://rijksvaccinatieprogramma.nl/english
----------------------------------------------------------------------------------------------


MAJOR HISTORICAL CHANGES

2002 (September): MenC vaccination was introduced, with a catch-up campaign for all 14 months-18 years.

2003 (March): Hib was added to DTwP and IPV in a combined vaccine at 2, 3, 4 and 11 months.

2003 (March): HepB vaccination was introduced for children of parents from a hepatitis B endemic area.

2005 (January): Accellular pertussis replaced whole-cell pertussis at 2, 3, 4 and 11 months.

2006 (January): A birth dose of HepB was introduced for children born to mothers infected with hepatitis B.

2006 (June): Pneumococcal vaccination was introduced at 2, 3, 4 and 11 months.

2009 (September): HPV vaccination was introduced for girls only with three doses (0, +1 and +6 months), starting with birth cohort 1997 (additional catch-up campaign for birth cohorts 1993-1996)

2011 (May): Pneumococcal vaccination changed from 7-valent to 10-valent vaccine (for children born from 1-3-2011)

2011 (October): Transition to universal HepB vaccination (for children born from 1-8-2011), given in a combined vaccine with DTaP, IPV and Hib

2013 (November): Change to pneumococcal recommendation: 2+1 schedule instead of 3+1 schedule

2014 (January): Change to HPV recommendation. For girls under age 15, Cervarix can be adminsitered in a 2 dose schedule instead of 3 previously.
The 0-1-6-schedule in under 15's is replaced by two doses in a 0-6-schedule.
Further information for those that are currently completing HPV vaccination is available from www.prikkenteller.nl

2018: May 2018, MenC vaccination at 14 months of age has been replaced by MenACWY. From October 2018, 13-14 year olds (in the year they turn 14 years) have been vaccinated with MenACWY vaccination. A catch-up campaign was conducted in 2018-2019 targeting 14-18 year olds.

From 2021: HPV vaccination will be extended to boys

2022: HPV as a 2-dose schedule at 15 years of age (2 doses 6 months apart)

2024: introduction of Rota vaccination for those born from 1 Jan. 2024

2024: 11 months DTapIPV-Hib-HepB dose changed to 12 monts


----------------------------------------------------------------------------------------------

Date of last update: 4 February 2026
----------------------------------------------------------------------------------------------